Pfizer Breathes Easy: FDA Approves Exubera
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer's Exubera is the first inhaled insulin to clear FDA; labeling recommends lung function testing.
You may also be interested in...
Pfizer’s Exubera Receives Nicer Recommendations From U.K.’s NICE
The group recommends inhaled insulin for diabetes patients with problems finding injection sites and injection phobias.
Pfizer’s Exubera Receives Nicer Recommendations From U.K.’s NICE
The group recommends inhaled insulin for diabetes patients with problems finding injection sites and injection phobias.
Lilly/Amylin Look To Limit Byetta Access Due To Cartridge Shortage
Exenatide supplies for patients already on the therapy will be maintained, Lilly said.